Means Investment Co., Inc. Abb Vie Inc. Transaction History

Means Investment Co., Inc.

$882 Million
Q3 2024

A detailed history of Means Investment Co., Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Means Investment Co., Inc. holds 27,697 shares of ABBV stock, worth $4.86 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

27,697

Previous 27,554 0.52%

Holding current value

$4.86 Million

Previous $4.73 Million 15.72%

% of portfolio

0.62%

Previous 0.58%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$163.84 - $199.33 $23,429 - $28,504	143 Added 0.52%	27,697 $5.47 Million
Q2 2024 Jul 19, 2024	SELL	$154.79 - $180.76 $276,919 - $323,379	-1,789 Reduced 6.1%	27,554 $4.73 Million
Q1 2024 Apr 17, 2024	SELL	$159.82 - $182.1 $31,484 - $35,873	-197 Reduced 0.67%	29,343 $5.34 Million
Q4 2023 Jan 25, 2024	BUY	$137.6 - $154.97 $14,585 - $16,426	106 Added 0.36%	29,540 $4.58 Million
Q3 2023 Oct 25, 2023	SELL	$133.59 - $154.65 $10,420 - $12,062	-78 Reduced 0.26%	29,434 $4.39 Million
Q2 2023 Jul 31, 2023	SELL	$132.51 - $164.9 $8,480 - $10,553	-64 Reduced 0.22%	29,512 $3.98 Million
Q1 2023 May 08, 2023	BUY	$144.61 - $166.54 $14,171 - $16,320	98 Added 0.33%	29,576 $4.71 Million
Q4 2022 Jan 27, 2023	BUY	$138.31 - $165.87 $10,649 - $12,771	77 Added 0.26%	29,478 $0
Q3 2022 Oct 17, 2022	SELL	$134.21 - $153.93 $53,952 - $61,879	-402 Reduced 1.35%	29,401 $3.95 Million
Q2 2022 Jul 21, 2022	SELL	$137.62 - $174.96 $29,725 - $37,791	-216 Reduced 0.72%	29,803 $4.57 Million
Q1 2022 Apr 26, 2022	BUY	$131.98 - $163.75 $6,598 - $8,187	50 Added 0.17%	30,019 $4.87 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $8,594 - $10,874	80 Added 0.27%	29,969 $4.06 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $4,788 - $5,435	-45 Reduced 0.15%	29,889 $3.22 Million
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $23,777 - $26,489	226 Added 0.76%	29,934 $3.37 Million
Q1 2021 Apr 05, 2021	BUY	$102.3 - $112.62 $19,334 - $21,285	189 Added 0.64%	29,708 $3.22 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $84,112 - $113,560	1,045 Added 3.67%	29,519 $3.06 Million
Q3 2020 Nov 09, 2020	SELL	$85.91 - $100.83 $15,034 - $17,645	-175 Reduced 0.61%	28,474 $2.64 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $15,040 - $20,126	205 Added 0.72%	28,649 $2.66 Million
Q1 2020 Apr 23, 2020	SELL	$64.5 - $97.79 $7,611 - $11,539	-118 Reduced 0.41%	28,444 $2.32 Million
Q4 2019 Jan 21, 2020	SELL	$72.13 - $90.25 $17,166 - $21,479	-238 Reduced 0.83%	28,562 $2.51 Million
Q3 2019 Nov 05, 2019	BUY	$62.98 - $75.72 $818 - $984	13 Added 0.05%	28,800 $2.39 Million
Q2 2019 Aug 07, 2019	SELL	$65.7 - $83.98 $56,699 - $72,474	-863 Reduced 2.91%	28,787 $2.05 Million
Q1 2019 Apr 16, 2019	BUY	$77.14 - $90.79 $795,081 - $935,772	10,307 Added 53.29%	29,650 $2.39 Million
Q4 2018 Apr 16, 2019	BUY	$77.85 - $96.01 $1.51 Million - $1.86 Million	19,343 New	19,343 $1.78 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Means Investment Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Means Investment Co., Inc. with notifications on news.

Account

Means Investment Co., Inc. Abb Vie Inc. Transaction History